Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 2013 and 20Y2, is shown as follows: Dec. 31, 2013 Dec. 31, 2012 Assets Cash $235,060 $219,170 85,150 78,720 Accounts receivable (net) Inventories Investments 240,390 233,050 0 90,290 Land 123,300 0 265,220 206,050 Equipment Accumulated depreciation-equipment Total assets (55,560) (62,090) $887,030 $771,720 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $160,550 $152,030 Accrued expenses payable operating expenses) 15,970 20,060 Dividends payable 8,870 6,950 Common stock, $10 par 47,900 37,810 Paid-in capital: Excess of issue price over par-common stock 180,070 104,950 Retained earnings 473,670 449,920 Total liabilities and stockholders' equity $887,030 $771,720 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: a. The investments were sold for $105,640 cash. b. Equipment and land were acquired for cash. C. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $60,020 credit to Retained Earnings for net income. f. There was a $36,270 debit to Retained Earnings for cash dividends declared. Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments. Livers Inc. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash flows from operating activities: Net income Adjustments to reconcile net income to net cash flow from operating activities: Depreciation Gain on sale of investments Changes in current operating assets and liabilities: $ Net cash flow from operating activities Cash flows from investing activities: $ Net cash flow used for investing activities Cash flows from financing activities: $ Net cash flow from financing activities ini) Cash at the beginning of the year Cash at the end of the year